Wednesday, April 18, 2012

Abbott Shows Off Positive Ph3 Parkinson's Data - Apr. 18, 2012

Having trouble viewing this email? View in Browser.
ClinicaSpace Focus
   Wednesday, April 18, 2012 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

Reduce Risk and Maximize Potential in Ophthalmology Development

Ophthalmic study design and execution can be quite different than other therapeutic areas. Pharm-Olam's team has a proven track record of excellence in achieving trial objectives and can provide strategic, operational and consulting to sponsors for phase I to phase IV development.

The majority of our clinical staff in emerging markets are MDs or PhDs, including Ophthalmologists in strategic areas for clinical trials. The incidence of disorders and standards of treatment can vary widely, so let Pharm-Olam conduct a complimentary feasibility study specific to your protocol and study budgets to use in your resource planning.

Contact us at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-1344-891121.
HeadHtml
•  Abbott Laboratories (ABT) Shows Off Positive Ph3 Parkinson's Data More...
•  Cubist Pharmaceuticals, Inc. (CBST) Announces Positive Results from ENTEREG® Phase 4 Study in Patients Undergoing Radical Cystectomy More...
•  Boehringer Ingelheim Pharmaceuticals, Inc. Release: New Sub-Analysis Evaluates Outcomes Associated with Lower Intracranial Hemorrhage Rates for Pradaxa® (dabigatran etexilate mesylate) Versus Warfarin in the RE-LY® Trial More...
•  Fibrocell Science, Inc. Release: LAVIV™ (azficel-T) Pivotal Trial Data Published in Peer-Reviewed Journal, Dermatologic Surgery More...
•  Janssen Pharmaceutica N.V. Release: INCIVO® (Telaprevir) SVR Rates Unaffected by Ribavirin Dose Reduction in Treatment Naive and Previously Treated Patients With Genotype-1 Chronic HCV More...
More Phase III News
More Phase II News
More Phase I News
More Pre-Clinical News
More Post-Approval News
HeadHtml
•  FDA Issues Complete Response Letter for the Pliaglis sNDA Submission More...
•  Depomed, Inc. (DEPO) Announces Intent to File NDA for Serada for Treatment of Menopausal Hot Flashes More...
•  Tengion Inc. Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013 More...
More BLA/NDA/ANDA News
More IND News
More MAA News
Featured Free Resource

Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing

This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.

Request Now!
HeadHtml
•  Testosterone May Help Heart Failure Patients, University of Alberta Study More...
•  Bring Water Into Exams to Improve Your Grade, University of East London Study More...
•  Being an Optimist May Protect Against Heart Problems, Harvard School of Public Health Study More...
•  It Doesn't Mean You're Crazy - Talking to Yourself Has Cognitive Benefits, University of Wisconsin-Madison Study More...
•  AspenBio Pharma, Inc.'s Clinical Study Suggests One-Third of CT Scans Used to Assess Pediatric and Adolescent Patients at Low Risk for Acute Appendicitis Could Potentially Be Avoided More...
More General Clinical Research News
Events

2012 Workshop on Protein Aggregation and Immunogenicity
July 9-12, 2012
Early Registration: $695 - $1,395

Aggregation of therapeutic proteins can occur during bioprocessing, shipping, storage and even delivery to the patient. Understanding of the roles of aggregates in immunogenicity of therapeutic protein products is critical. Such immune responses can have serious consequences for patients. Also, immunogenicity can be major stumbling blocks to product development and has even plagued licensed protein therapeutics. To increase understanding of the impact of protein aggregation on immunogenicity, the Workshop will focus on five central areas:

1) clinical aspects of immunogenicity to therapeutic proteins;
2) utility of animal models and in vitro cell assays for assessing immunogenicity of aggregates and particles;
3) causes and control of aggregates and particles in formulations;
4) causes and control of aggregates and particles during processing; and
5) insights and challenges with analytical methods.

Please note: The early registration fee expires May 1, 2012, and includes a buffet for breakfast and lunch each day, opening and closing receptions, and a workshop notebook.

To register and view the schedule of speakers by industry leader's visit our website.
Latest Market Insight

New Emerging R&D and Clinical Trial Locations

• Compare 5 new emerging R&D locations in terms of population, economic activity, healthcare infrastructure, and current R&D activity.
• Analyze how clinical trial numbers are changing in China, India, and Eastern Europe.
• Develop strategies for geographic outsourcing.

Click Here for More Information.
Tower: Facebook
Top Jobs
Biotech Beach (Irvine, California)

Allergan Inc.
Senior Manager, Clinical Quality
Design and oversee delivery of quality training programs to Global Development staff for controlled procedural and processes training. Design, lead and manage the development, maintenance, and delivery of Global Development training consistent with regional and global CFR / ICH GCP / ISO regulatory requirements.

Genetown (Billerica, Massachusetts)

PAREXEL International
Clinical Logistics Leader, Proposal Support
Ensures that clinical logistics projects are progressing and systems are set up and maintained according to quality standards, SOPs and applicable ICH-GxP* and other applicable industry guidelines.

Southern Pharm (Jacksonville, Florida)

Ipsen
Endo Clinical Science Specialist
Responsible for the sales of Increlex, Somatuline Depot and other products as they become available, to clinicians in his/her area of responsibility. The CSS will sell the values, features and benefits of Ipsen and its products to customers within the assigned territory which includes: North Florida, Alabama, Mississippi, and Louisiana.

Pharm Country (Wallingford, Connecticut)

Alpha Consulting
Clinical SAS Programmer
Contribute to computer programming efforts for a clinical trial drug project and to provide programming support for clinical trial data reporting and regulatory submissions.

Biotech Bay (San Francisco, California)

FibroGen, Inc.
Senior Clinical Data Manager
Responsible for overseeing Data Management (DM) operational activities, ensuring compliance with the corporate timeline and scope of work outsourced to the DM service provider (SP) and coordinating activities from other external vendors that may also provide study data.

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!


Pharm Country

BioCapital Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Mid-Atlantic region.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

BioCapital Career Fair, Bethesda, MD April 25, 2012
Pharm Country Career Fair, King Of Prussia, PA May 1, 2012
BioNC Career Fair, Durham, NC May 2, 2012
Biotech Bay Career Fair, Burlingame, CA May 29, 2012

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
HeadHtml
•  First Patent for Translation Risk Management Awarded to Crimson Life Sciences More...
More Patent News
HeadHtml
•  Roche (RHHBY)'s Avastin Rejected by National Institute for Clinical Excellence (NICE) for Use in Breast Cancer More...
•  Sucampo Pharmaceuticals, Inc. and Clinigen Announce Named Patient Program for European Union, Iceland and Norway to Provide Access to AMITIZA® (lubiprostone) for Chronic Idiopathic Constipation Patients More...
More Drug Product News
Feature

Hot Company

SGS Life Science Services
201 Route 17 North
Rutherford, New Jersey 07070 U.S.A.
Phone: 201-508-3000

SGS Life Science Services is a leading contract service organization providing clinical research, analytical development, biologics characterization, and quality control testing. SGS serves various life science companies, including pharmaceutical, biopharmaceutical, biotechnology, and medical-device manufacturers.

More Company Profiles
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

ClinicaSpace
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
ClinicaSpace
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the ClinicaSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

ClinicaSpace.com - Clinical Trials. Clinical Research. Community.
Legal Notice
• ClinicaSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 ClinicaSpace http://www.clinicaspace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.
 


No comments: